Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin-based Sequential vs Triple Therapy for Refractory H. Pylori
NCT01537055Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01537055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537055.